BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 87.95 |
| Open | 88.39 |
| Bid | 88.79 x 100 |
| Ask | 88.89 x 100 |
| Day's Range | 87.95 - 89.58 |
| 52 Week Range | 85.21 - 125.83 |
| Volume | |
| Avg. Volume | 587,885 |
| Market Cap | 21.405B |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | 21.66 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 02, 2022 |
| 1y Target Est | N/A |
- Zacks
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.
- The Telegraph
Wall Street plunges after US inflation shock
US stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
- Reuters
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.
© 2024 Yahoo. All rights reserved.